CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions		3 Months Ended
		Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net (loss) income		$ (104.0)	$ 152.3
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Amortization and impairment of software development costs and licenses		47.5	24.5
Stock-based compensation		43.9	49.1
Noncash lease expense		11.4	9.4
Amortization of intellectual property		117.6	15.2
Depreciation		17.5	12.5
Impairment of software development costs and licenses		19.9	9.8
Amortization of debt issuance costs		8.6	0.0
Interest expense		20.7	0.0
Fair value adjustments		39.6	2.0
Other, net		(25.0)	1.9
Changes in assets and liabilities, net of effect from purchases of businesses:
Accounts receivable		214.9	74.7
Software development costs and licenses		(103.5)	(85.9)
Prepaid expenses and other current and other non-current assets		(67.6)	19.4
Deferred revenue		(159.5)	(94.7)
Accounts payable, accrued expenses and other liabilities		18.8	(42.0)
Net cash provided by operating activities		100.8	148.2
Investing activities:
Change in bank time deposits		125.6	311.9
Proceeds from available-for-sale securities		242.8	161.2
Purchases of available-for-sale securities		0.0	(302.5)
Purchases of fixed assets		(42.5)	(86.4)
Purchases of long-term investments		(5.1)	(0.1)
Business acquisitions		(3,128.1)	(97.9)
Net cash used in investing activities		(2,807.3)	(13.8)
Financing activities:
Tax payment related to net share settlements on restricted stock awards		(53.9)	(48.3)
Issuance of common stock		11.4	9.2
Payment for settlement of convertible notes		(1,166.8)	0.0
Proceeds from issuance of debt		3,248.9	0.0
Cost of debt		(22.6)	0.0
Net cash provided by (used in) financing activities		2,017.0	(39.1)
Effects of foreign currency exchange rates on cash, cash equivalents, and restricted cash and cash equivalents		(14.7)	1.8
Net change in cash, cash equivalents, and restricted cash and cash equivalents		(704.2)	97.1
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of year	[1]	2,195.3	2,060.2
Cash, cash equivalents, and restricted cash and cash equivalents, end of period	[1]	$ 1,491.1	$ 2,157.3

[1] Cash, cash equivalents and restricted cash and cash equivalents shown on our Condensed Consolidated Statements of Cash Flow includes amounts in the Cash and cash equivalents, Restricted cash and cash equivalents, and Long-term restricted cash and cash equivalents on our Condensed Consolidated Balance Sheet.